TABLE 1.
N | Gender | Range of deep venous thrombosis | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Male | Female | Comorbidities | I | II | III | ||||||||||
n | % | n | % | Age (years) | Body mass index | n | % | n | % | n | % | n | % | ||
Group A | 35 | 25 | 71.4 | 10 | 28.6 | 62.4 ± 10.2 | 22.3 ± 1.9 | 26 | 72.3 | ||||||
Group B | 46 | 29 | 63.0 | 17 | 37.0 | 61.1 ± 14.1 | 21.8 ± 2.0 | 32 | 69.5 | ||||||
Group A+ | 33 | 23 | 70.0 | 10 | 30.0 | 62.8 ± 10.3 | 22.6 ± 1.7 | 24 | 72.7 | 24 | 72.7 | 7 | 21.3 | 2 | 6.0 |
Group B+ | 22 | 14 | 63.6 | 8 | 36.4 | 61.3 ± 13.3 | 22.0 ± 1.6 | 15 | 68.2 | 16 | 72.7 | 5 | 22.7 | 1 | 4.6 |
Note: Comorbidities—hypertension, hyperglycemia, coronary atherosclerotic heart disease, cerebral infarction, cerebral hemorrhage, malignant tumor, chronic obstructive pulmonary disease, etc. I: Intermuscular vein; II: Intermuscular vein, peroneal vein and posterior tibial vein; III: Intermuscular vein, peroneal vein, posterior tibial vein, popliteal vein and above.